ESR1 and breast carcinoma: Tumor necrosis was linked to aggressive tumor features, including loss of ER- , PR expression, HER2 positivity and appeared almost exclusively associated (98%) with the Basal-like molecular breast cancer subtype (Fig. 1B and Table 3).